Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 201

Sort by

Sort Order Select

Journal Articles

Platelet Desialylation As a Predictive Marker in Childhood Immune Thrombocytopenia (ITP)

Leona Raskova Kafkova, MSc, PhD, Diana Brokesova, MSc, Zbynek Novak, MD, Milan Raska, Prof. MD MSc, PhD, Dagmar Pospisilova, Prof MD PhD, Jana Volejnikova, MD

Blood (2019) 134 (Supplement_1): 221.

https://doi.org/10.1182/blood-2019-122095

Published: 2019

Journal Articles

An Adapting Bone Marrow Niche Creates a Nurturing Environment for Hematopoiesis during Immune Thrombocytopenia Progression

Oliver Herd, BSc, Maria Abril Arredondo Garcia, BSc, James Hewitson, PhD, Karen Hogg, PhD, Saleni Pravin Kumar, BSc, Katiuska Pulgar Prieto, BSc, Andrew Stone, BSc, Paul Genever, PhD, Ian Hitchcock, PhD

Blood (2019) 134 (Supplement_1): 222.

https://doi.org/10.1182/blood-2019-129795

Published: 2019

Journal Articles

Racial Variation in ITP Prevalence and Rate of Chronic Disease Suggests Biological Differences

Lauryn S. Walker, Taylor Olmsted Kim, MD, Amanda Bell Grimes, MD, Susan Kirk, PA-C, Audrey S. Cohen, Abinaya Arulselvan, Scott E. Wenderfer, MD, Michele P. Lambert, MD, Jenny M. Despotovic, DO, MS

Blood (2019) 134 (Supplement_1): 387.

https://doi.org/10.1182/blood-2019-130418

Published: 2019

Journal Articles

Megakaryocyte Morphological Classification Based Predictive Model for Steroid Sensitivity in Primary Immune Thrombocytopenia

Mixue Xie, Jingjing Zhu, Yanlong Zheng, Xueying Li, Xianbo Huang, MD PhD, Xiujin Ye, MD PhD

Blood (2019) 134 (Supplement_1): 4911.

https://doi.org/10.1182/blood-2019-123627

Published: 2019

Journal Articles

Serum Complement Levels in Immune Thrombocytopenia: Characterization and Relation to Clinical Features

Abraham Z Cheloff, MS, David J. Kuter, Hanny Al-Samkari, MD

Blood (2019) 134 (Supplement_1): 1087.

https://doi.org/10.1182/blood-2019-125341

Published: 2019

Journal Articles

Phase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia

David J. Kuter, Ralph V. Boccia, MD, Eun-Ju Lee, MD, Merlin Efraim, MD, Nikolay Tzvetkov, MD, Jiri Mayer, MD, Marek Trněný, MD, Milan Kostal, MD, Roman Hajek, MD, Vickie McDonald, MD, Olga Bandman, MD, Regan Burns, Ann Neale, Dolca Thomas, MD, Nichola Cooper, MD MRCP

Blood (2019) 134 (Supplement_1): 87.

https://doi.org/10.1182/blood-2019-122336

Published: 2019

Journal Articles

Next Generation Sequencing-Based Characterization of T Cell Receptor Repertoire of Patients with Immune Thrombocytopenia

Panpan Han, Xiaoqing You, Clara Lo, MD, Liwen Xu, Haiyu Zhang, James L Zehnder, Bing Melody Zhang

Blood (2019) 134 (Supplement_1): 2347.

https://doi.org/10.1182/blood-2019-127590

Published: 2019

Journal Articles

The Role of M2 Macrophage in Primary Immune Thrombocytopenia

Xia Shao, Boting Wu, Pu Chen, Yanxia Zhan, Feng Li, Fanli Hua, Lihua Sun, Yunfeng Cheng, MD PhD

Blood (2019) 134 (Supplement_1): 2355.

https://doi.org/10.1182/blood-2019-129667

Published: 2019

Journal Articles

Rituximab Yielded a Significantly Longer Response Compared to Placebo in Steroid Free Population - a Post Hoc Analysis of the Ritp Study

Waleed Ghanima, MD PhD, Marc Michel, Abderrahim Khelif, Bernadette Darne, Pal André Holme, PhDMD

Blood (2019) 134 (Supplement_1): 2358.

https://doi.org/10.1182/blood-2019-126975

Published: 2019

Journal Articles

Potential Anti-Thrombotic Effect without Accompanying Hemorrhage with Fostamatinib Use in Patients with Immune Thrombocytopenia

Ivy Altomare, MD, Vadim V. Markovtsov, PhD, Leslie Todd, Dheepika Weerasinghe, PhD, Robert P. Numerof, PhD, Sandy Tong, MD, Esteban Masuda, PhD, James B. Bussel, MD

Blood (2019) 134 (Supplement_1): 4889.

https://doi.org/10.1182/blood-2019-126558

Published: 2019

Journal Articles

Combination of ATRA and High-Dose Dexamethasone As First-Line Treatment in Adult Immune Thrombocytopenia:a Randomized, Phase 2, Open-Label Trial

Qiu-Sha Huang, Yi Liu, Jing-Bo Wang, Jun Peng, Ming Hou, Hui Liu, Jing-Wen Wang, Lan-Ping Xu, Kaiyan Liu, Xiao-Jun Huang, MD, Xiao-Hui Zhang

Blood (2019) 134 (Supplement_1): 899.

https://doi.org/10.1182/blood-2019-125242

Published: 2019

Journal Articles

High-Dose Dexamethasone (HD-DXM) Plus Oseltamivir Versus High-Dose Dexamethasone for Treatment of Adult Primary Immune Thrombocytopenia: Interim Analysis of a Prospective, Multicenter, Randomized, Controlled Trial

Lu Sun, PhD, Xinguang Liu, Hai Zhou, Hongguo Zhao, Chenglu Yuan, Daqi Li, Zhencheng Wang, Yu Hou, Jun Peng, Ming Hou

Blood (2019) 134 (Supplement_1): 900.

https://doi.org/10.1182/blood-2019-121825

Published: 2019

Journal Articles

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Ralph Boccia, MD, Michael A. Boxer, MD, Waleed Ghanima, MD PhD, Quentin A. Hill, Michelle Sholzberg, MDBSc,FRCPC,MSc, Michael D. Tarantino, MD, Yuliya Kreychman, PharmD, Robert P. Numerof, PhD, Brian Olender, BA, Leslie Todd, Sandy Tong, MD, Anne-Marie Duliege, MDMS, Nichola Cooper, MD MRCP, James B. Bussel, MD

Blood (2019) 134 (Supplement_1): 1069.

https://doi.org/10.1182/blood-2019-126473

Published: 2019

Journal Articles

Long Term Remission Achieved By Fostamatinib in ITP: A Case Report

Waleed Ghanima, MD PhD, Tjønnfjord Eirik, MD PhD

Blood (2019) 134 (Supplement_1): 4901.

https://doi.org/10.1182/blood-2019-128359

Published: 2019

Journal Articles

Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia

Hanny Al-Samkari, MD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 734.

https://doi.org/10.1182/blood-2018-99-117267

Published: 2018

Journal Articles

PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis

Mu Nie, Qi Feng, Yu Hou, Miao Xu, MSc,MD, Jun Peng, MDPhD, Ming Hou, MD PhD, Yan Shi, MD

Blood (2018) 132 (Supplement 1): 3700.

https://doi.org/10.1182/blood-2018-99-116069

Published: 2018

Journal Articles

Human Leukocyte Antigen-G Restores Immune Tolerance in Immune Thrombocytopenia

Qi Feng, Ji Ma, Xin Li, Ming Hou, Jun Peng, MD PhD

Blood (2018) 132 (Supplement 1): 3751.

https://doi.org/10.1182/blood-2018-99-115713

Published: 2018

Journal Articles

Aberrant Expression of a Proliferation-Inducing Ligand Underlies Autoimmune Mechanisms in Immune Thrombocytopenia

Yunfeng Hao, Renchi Yang, MD, Zeping Zhou

Blood (2018) 132 (Supplement 1): 3763.

https://doi.org/10.1182/blood-2018-99-111743

Published: 2018

Journal Articles

Prediction of Response to Fostamatinib Based on the Presence of Plasma Platelet Autoantibodies in Adult Patients with Immune Thrombocytopenia (ITP) — Exploratory Analyses from Phase 3 Studies

Vadim V. Markovtsov, PhD, Sothy Yi, Chi Young, Anne-Marie Duliege, MD MS, Esteban Masuda, PhD

Blood (2018) 132 (Supplement 1): 3766.

https://doi.org/10.1182/blood-2018-99-113705

Published: 2018

Journal Articles

Therapeutic Effect of Platelet Transfusion in Patients with Acute Lymphocytes Treated with CART Therapy

Liu Yan, MD, Xie Jue, MD PhD, Yongxian Hu, MD PhD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 5073.

https://doi.org/10.1182/blood-2018-99-120108

Published: 2018

NARROW

Platelet Desialylation As a Predictive Marker in Childhood Immune Thrombocytopenia (ITP)

An Adapting Bone Marrow Niche Creates a Nurturing Environment for Hematopoiesis during Immune Thrombocytopenia Progression

Racial Variation in ITP Prevalence and Rate of Chronic Disease Suggests Biological Differences

Megakaryocyte Morphological Classification Based Predictive Model for Steroid Sensitivity in Primary Immune Thrombocytopenia

Serum Complement Levels in Immune Thrombocytopenia: Characterization and Relation to Clinical Features

Phase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia

Next Generation Sequencing-Based Characterization of T Cell Receptor Repertoire of Patients with Immune Thrombocytopenia

The Role of M2 Macrophage in Primary Immune Thrombocytopenia

Rituximab Yielded a Significantly Longer Response Compared to Placebo in Steroid Free Population - a Post Hoc Analysis of the Ritp Study

Potential Anti-Thrombotic Effect without Accompanying Hemorrhage with Fostamatinib Use in Patients with Immune Thrombocytopenia

Combination of ATRA and High-Dose Dexamethasone As First-Line Treatment in Adult Immune Thrombocytopenia:a Randomized, Phase 2, Open-Label Trial

High-Dose Dexamethasone (HD-DXM) Plus Oseltamivir Versus High-Dose Dexamethasone for Treatment of Adult Primary Immune Thrombocytopenia: Interim Analysis of a Prospective, Multicenter, Randomized, Controlled Trial

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Long Term Remission Achieved By Fostamatinib in ITP: A Case Report

Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia

PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis

Human Leukocyte Antigen-G Restores Immune Tolerance in Immune Thrombocytopenia

Aberrant Expression of a Proliferation-Inducing Ligand Underlies Autoimmune Mechanisms in Immune Thrombocytopenia

Prediction of Response to Fostamatinib Based on the Presence of Plasma Platelet Autoantibodies in Adult Patients with Immune Thrombocytopenia (ITP) — Exploratory Analyses from Phase 3 Studies

Therapeutic Effect of Platelet Transfusion in Patients with Acute Lymphocytes Treated with CART Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only